BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22559715)

  • 1. Fibroblasts from phenotypically normal palmar fascia exhibit molecular profiles highly similar to fibroblasts from active disease in Dupuytren's Contracture.
    Satish L; LaFramboise WA; Johnson S; Vi L; Njarlangattil A; Raykha C; Krill-Burger JM; Gallo PH; O'Gorman DB; Gan BS; Baratz ME; Ehrlich GD; Kathju S
    BMC Med Genomics; 2012 May; 5():15. PubMed ID: 22559715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased CCT-eta expression is a marker of latent and active disease and a modulator of fibroblast contractility in Dupuytren's contracture.
    Satish L; O'Gorman DB; Johnson S; Raykha C; Gan BS; Wang JH; Kathju S
    Cell Stress Chaperones; 2013 Jul; 18(4):397-404. PubMed ID: 23292503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts.
    Satish L; Gallo PH; Baratz ME; Johnson S; Kathju S
    BMC Musculoskelet Disord; 2011 May; 12():113. PubMed ID: 21612641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren's disease and adjacent palmar fascia cells.
    Vi L; Feng L; Zhu RD; Wu Y; Satish L; Gan BS; O'Gorman DB
    Exp Cell Res; 2009 Dec; 315(20):3574-86. PubMed ID: 19619531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of contractile force by cultured Dupuytren's disease and normal palmar fibroblasts.
    Rayan GM; Tomasek JJ
    Tissue Cell; 1994 Oct; 26(5):747-56. PubMed ID: 9437248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The collagen changes of Dupuytren's contracture.
    Murrell GA; Francis MJ; Bromley L
    J Hand Surg Br; 1991 Aug; 16(3):263-6. PubMed ID: 1960490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
    Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
    J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptors in Dupuytren's contracture.
    Pagnotta A; Specchia N; Greco F
    J Orthop Res; 2002 Jan; 20(1):163-8. PubMed ID: 11853085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of differentially expressed genes in fibroblasts derived from patients with Dupuytren's Contracture.
    Satish L; LaFramboise WA; O'Gorman DB; Johnson S; Janto B; Gan BS; Baratz ME; Hu FZ; Post JC; Ehrlich GD; Kathju S
    BMC Med Genomics; 2008 Apr; 1():10. PubMed ID: 18433489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a novel gene, MafB, in Dupuytren's disease.
    Lee LC; Zhang AY; Chong AK; Pham H; Longaker MT; Chang J
    J Hand Surg Am; 2006 Feb; 31(2):211-8. PubMed ID: 16473681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA sequencing reveals a depletion of collagen targeting microRNAs in Dupuytren's disease.
    Riester SM; Arsoy D; Camilleri ET; Dudakovic A; Paradise CR; Evans JM; Torres-Mora J; Rizzo M; Kloen P; Julio MK; van Wijnen AJ; Kakar S
    BMC Med Genomics; 2015 Oct; 8():59. PubMed ID: 26446724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease.
    Brickley-Parsons D; Glimcher MJ; Smith RJ; Albin R; Adams JP
    J Bone Joint Surg Am; 1981 Jun; 63(5):787-97. PubMed ID: 7240301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
    Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
    J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture.
    Qian A; Meals RA; Rajfer J; Gonzalez-Cadavid NF
    Urology; 2004 Aug; 64(2):399-404. PubMed ID: 15302515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the effects of Pirfenidone on TGF-β1 stimulated non-SMAD signaling pathways in Dupuytren's disease -derived fibroblasts.
    Zhou C; Zeldin Y; Baratz ME; Kathju S; Satish L
    BMC Musculoskelet Disord; 2019 Mar; 20(1):135. PubMed ID: 30927912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of histological patterns in clinically affected and unaffected palm regions in dupuytren's disease.
    Alfonso-Rodríguez CA; Garzón I; Garrido-Gómez J; Oliveira AC; Martín-Piedra MÁ; Scionti G; Carriel V; Hernández-Cortés P; Campos A; Alaminos M
    PLoS One; 2014; 9(11):e112457. PubMed ID: 25379672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of 5-fluorouracil on Dupuytren fibroblast proliferation and differentiation.
    Jemec B; Linge C; Grobbelaar AO; Smith PJ; Sanders R; McGrouther DA
    Chir Main; 2000 Feb; 19(1):15-22. PubMed ID: 10777424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts.
    Tomasek J; Rayan GM
    J Hand Surg Am; 1995 May; 20(3):450-5. PubMed ID: 7642925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing an animal model of Dupuytren's disease by orthotopic transplantation of human fibroblasts into athymic rat.
    Satish L; Palmer B; Liu F; Papatheodorou L; Rigatti L; Baratz ME; Kathju S
    BMC Musculoskelet Disord; 2015 Jun; 16():138. PubMed ID: 26049932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts.
    Zhou C; Liu F; Gallo PH; Baratz ME; Kathju S; Satish L
    BMC Musculoskelet Disord; 2016 Nov; 17(1):469. PubMed ID: 27835939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.